Categories: News

NYSE Content Update: Disney Names New CEO After Ringing Bell on Main Street USA

NYSE issues a pre-market daily advisory direct from the trading floor.

- Advertisement -

NEW YORK, Feb. 4, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Ashley Mastronardi delivers the pre-market update on February 4th

- Advertisement -
  • Stocks are moving higher early Wednesday as traders rotate into economically sensitive sectors. Small-cap stocks have benefited, and Gold returned to $5,000 an ounce.
  • Disney (NYSE: DIS) announced yesterday that Josh D’Amaro will succeed longtime CEO Bob Iger, effective on March 18th, 2026. Iger and D’Amaro joined NYSE President Lynn Martin last July to ring the Opening Bell from Main Street USA.
  • Veradermics (NYSE: MANE), a hair loss biotech company, is set to debut on the NYSE today. It raised $256 million in an upsized IPO and sold over 15 million shares at $17 each.

Opening Bell
Citigroup (NYSE: C) celebrates Black History Month

- Advertisement -

Closing Bell
Radian Group (NYSE: RDN) celebrates the acquisition of Inigo Limited

- Advertisement -

For market insights, IPO activity, and today’s opening bell, download the NYSE TV App: TV.NYSE.com

- Advertisement -

 

- Advertisement -

Video – https://mma.prnewswire.com/media/2876902/NYSE_Market_Update_Feb_4.mp4 
Photo – https://mma.prnewswire.com/media/2876901/NYSE_Market_Update_Feb_4___Disney.jpg
Logo – https://mma.prnewswire.com/media/2581322/5752076/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-update-disney-names-new-ceo-after-ringing-bell-on-main-street-usa-302679026.html

- Advertisement -

Recent Posts

Deepak Group Goes Beyond Green with hands-On Mangrove Restoration

Deepak Group undertakes mangrove plantation drive on World Environment DaySustainable restoration along the Paniyadra coast,…

3 hours ago

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…

7 hours ago

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…

7 hours ago

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…

7 hours ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

June 05, 2026 20:13 ET  | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…

7 hours ago